Trends and Gaps in Awareness of Direct-to-Consumer Genetic Tests From 2007 to 2014

Nate C. Apathy, Terri Menser, Lindsay M. Keeran, Eric W. Ford, Chris Harle, Timothy R. Huerta

Research output: Contribution to journalArticle

Abstract

Introduction: Direct-to-consumer genetic tests for inherited disease risks have gained recent approvals from the Food and Drug Administration, and interest in these tests has continued to grow. Broad use of these tests coupled with planning and discussion with health providers regarding genetic risks and potential protective behavior changes have been proposed as preventive tools to reduce health disparities and improve equity in health outcomes. However, awareness of direct-to-consumer genetic testing has historically demonstrated differences by education, income, and race; these disparities could jeopardize potential benefits by limiting access and use. Methods: The national survey data from the Health Information National Trends Survey was analyzed to understand how overall awareness of direct-to-consumer genetic testing and disparities in awareness across sociodemographic groups have changed since 2007. Results: The findings showed persistent disparities, as well as a widening gap in awareness between Hispanics and non-Hispanic whites (OR2007 =1.52, OR2014 =0.58, pchange =0.0056), despite overall increases in awareness over time. Conclusions: Given these findings, policies regulating direct-to-consumer genetic tests should prioritize equitable distribution of benefits by including provisions that counteract prevailing disparities in awareness.

Original languageEnglish (US)
Pages (from-to)806-813
Number of pages8
JournalAmerican Journal of Preventive Medicine
Volume54
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Genetic Testing
Health
United States Food and Drug Administration
Health Surveys
Hispanic Americans
Education
Direct-To-Consumer Screening and Testing
Surveys and Questionnaires
Health Equity

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Trends and Gaps in Awareness of Direct-to-Consumer Genetic Tests From 2007 to 2014. / Apathy, Nate C.; Menser, Terri; Keeran, Lindsay M.; Ford, Eric W.; Harle, Chris; Huerta, Timothy R.

In: American Journal of Preventive Medicine, Vol. 54, No. 6, 01.06.2018, p. 806-813.

Research output: Contribution to journalArticle

Apathy, Nate C. ; Menser, Terri ; Keeran, Lindsay M. ; Ford, Eric W. ; Harle, Chris ; Huerta, Timothy R. / Trends and Gaps in Awareness of Direct-to-Consumer Genetic Tests From 2007 to 2014. In: American Journal of Preventive Medicine. 2018 ; Vol. 54, No. 6. pp. 806-813.
@article{e0c3aaaa45d84f7cb1bb818c911ecb8d,
title = "Trends and Gaps in Awareness of Direct-to-Consumer Genetic Tests From 2007 to 2014",
abstract = "Introduction: Direct-to-consumer genetic tests for inherited disease risks have gained recent approvals from the Food and Drug Administration, and interest in these tests has continued to grow. Broad use of these tests coupled with planning and discussion with health providers regarding genetic risks and potential protective behavior changes have been proposed as preventive tools to reduce health disparities and improve equity in health outcomes. However, awareness of direct-to-consumer genetic testing has historically demonstrated differences by education, income, and race; these disparities could jeopardize potential benefits by limiting access and use. Methods: The national survey data from the Health Information National Trends Survey was analyzed to understand how overall awareness of direct-to-consumer genetic testing and disparities in awareness across sociodemographic groups have changed since 2007. Results: The findings showed persistent disparities, as well as a widening gap in awareness between Hispanics and non-Hispanic whites (OR2007 =1.52, OR2014 =0.58, pchange =0.0056), despite overall increases in awareness over time. Conclusions: Given these findings, policies regulating direct-to-consumer genetic tests should prioritize equitable distribution of benefits by including provisions that counteract prevailing disparities in awareness.",
author = "Apathy, {Nate C.} and Terri Menser and Keeran, {Lindsay M.} and Ford, {Eric W.} and Chris Harle and Huerta, {Timothy R.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.amepre.2018.02.013",
language = "English (US)",
volume = "54",
pages = "806--813",
journal = "American Journal of Preventive Medicine",
issn = "0749-3797",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Trends and Gaps in Awareness of Direct-to-Consumer Genetic Tests From 2007 to 2014

AU - Apathy, Nate C.

AU - Menser, Terri

AU - Keeran, Lindsay M.

AU - Ford, Eric W.

AU - Harle, Chris

AU - Huerta, Timothy R.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Introduction: Direct-to-consumer genetic tests for inherited disease risks have gained recent approvals from the Food and Drug Administration, and interest in these tests has continued to grow. Broad use of these tests coupled with planning and discussion with health providers regarding genetic risks and potential protective behavior changes have been proposed as preventive tools to reduce health disparities and improve equity in health outcomes. However, awareness of direct-to-consumer genetic testing has historically demonstrated differences by education, income, and race; these disparities could jeopardize potential benefits by limiting access and use. Methods: The national survey data from the Health Information National Trends Survey was analyzed to understand how overall awareness of direct-to-consumer genetic testing and disparities in awareness across sociodemographic groups have changed since 2007. Results: The findings showed persistent disparities, as well as a widening gap in awareness between Hispanics and non-Hispanic whites (OR2007 =1.52, OR2014 =0.58, pchange =0.0056), despite overall increases in awareness over time. Conclusions: Given these findings, policies regulating direct-to-consumer genetic tests should prioritize equitable distribution of benefits by including provisions that counteract prevailing disparities in awareness.

AB - Introduction: Direct-to-consumer genetic tests for inherited disease risks have gained recent approvals from the Food and Drug Administration, and interest in these tests has continued to grow. Broad use of these tests coupled with planning and discussion with health providers regarding genetic risks and potential protective behavior changes have been proposed as preventive tools to reduce health disparities and improve equity in health outcomes. However, awareness of direct-to-consumer genetic testing has historically demonstrated differences by education, income, and race; these disparities could jeopardize potential benefits by limiting access and use. Methods: The national survey data from the Health Information National Trends Survey was analyzed to understand how overall awareness of direct-to-consumer genetic testing and disparities in awareness across sociodemographic groups have changed since 2007. Results: The findings showed persistent disparities, as well as a widening gap in awareness between Hispanics and non-Hispanic whites (OR2007 =1.52, OR2014 =0.58, pchange =0.0056), despite overall increases in awareness over time. Conclusions: Given these findings, policies regulating direct-to-consumer genetic tests should prioritize equitable distribution of benefits by including provisions that counteract prevailing disparities in awareness.

UR - http://www.scopus.com/inward/record.url?scp=85045336385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045336385&partnerID=8YFLogxK

U2 - 10.1016/j.amepre.2018.02.013

DO - 10.1016/j.amepre.2018.02.013

M3 - Article

VL - 54

SP - 806

EP - 813

JO - American Journal of Preventive Medicine

JF - American Journal of Preventive Medicine

SN - 0749-3797

IS - 6

ER -